Sort by
Refine Your Search
-
should have a PhD (or close to completion) in Physics, Planetary Sciences or Earth Sciences. It will be an advantage to have experience in remote sensing, analysis of thermal data, thermal modelling
-
challenges, from reducing our carbon emissions to developing vaccines during a pandemic. The Department of Psychiatry is based on the Warneford Hospital site in Oxford – a friendly, welcoming place of work
-
to appoint a Postdoctoral Research Assistant in Translational Biology to join our research team at Oxford Translational Myeloma Centre which is based at Botnar Research Centre, Nuffield Department
-
(approximately 3–6 months) based at the CMB in France, before continuing the remainder of the role in Oxford. This full-time fixed-term post is funded for up to 3 years in the first instance. The postholder will
-
experience in working with human neuronal cell lines that provide models of understanding the biology of protein aggregation and its phenotypes. About you Applicants must hold a PhD in Chemistry or a relevant
-
Postdoctoral Research Associate in Forest Resilience, Climate Change, and Human Health in the Amazon
, epidemiology, and socio-environmental modelling. To be considered a successful candidate; A PhD degree in Ecology, Biodiversity analyses, Environmental Science, Remote Sensing, Epidemiology, Data Science, or a
-
have completed, or be close to completing, a PhD/DPhil in a relevant quantitative field such as computational social science, computer science, or cognitive science. They will have a demonstrable track
-
Research Council and led by the University of Exeter (you will report to Professor Kate Saunders in Oxford). The post is based in the Department of Psychiatry at the Warneford Hospital Oxford. The post is
-
Institute for Molecular and Computational Medicine (IMCM). You will test GSK assets and targets in established models of podocyte and mesangial cell pathology relevant to glomerular diseases. You will
-
We are seeking a talented and motivated researcher to join the Mead Group to contribute to a major research programme focused on characterisation of in vivo models of myeloid neoplasms and